THC - Tenet Healthcare Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Dallas,
United States
Type: Equity
THC price evolution
THC
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2880 | $2481 | $1228 | |
| Short term investments | ||||
| Net receivables | $3296 | $2817 | $3148 | $2914 |
| Inventory | $356 | $382 | $395 | $411 |
| Total current assets | $8759 | $7955 | $7821 | $7167 |
| Long term investments | $3156 | $3244 | $3157 | |
| Property, plant & equipment | $5552 | $5857 | $5855 | $6236 |
| Goodwill & intangible assets | $12212 | $11967 | $11675 | |
| Total noncurrent assets | $21310 | $21086 | $21145 | |
| Total investments | $3156 | $3244 | $3157 | |
| Total assets | $29372 | $29265 | $28907 | $28312 |
| Current liabilities | ||||
| Accounts payable | $1265 | $1270 | $1335 | $1408 |
| Deferred revenue | ||||
| Short long term debt | $102 | $107 | $120 | |
| Total current liabilities | $5538 | $5493 | $5416 | $4760 |
| Long term debt | $12776 | $12769 | $12772 | $14882 |
| Total noncurrent liabilities | $15903 | $15820 | $18044 | |
| Total debt | $12871 | $12879 | $15002 | |
| Total liabilities | $25538 | $25790 | $21236 | $22804 |
| Shareholders' equity | ||||
| Retained earnings | $2690 | $2218 | $1959 | -$192 |
| Other shareholder equity | -$175 | -$177 | -$179 | -$181 |
| Total shareholder equity | $3475 | $3453 | $1608 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1228 | $858 | $2364 | $2446 |
| Short term investments | ||||
| Net receivables | $2914 | $2943 | $2770 | $2690 |
| Inventory | $411 | $405 | $384 | $368 |
| Total current assets | $7167 | $5981 | $7075 | $7147 |
| Long term investments | $3157 | $3147 | $3254 | $2534 |
| Property, plant & equipment | $6236 | $6462 | $6427 | $6692 |
| Goodwill & intangible assets | $11675 | $11547 | $10758 | $10408 |
| Total noncurrent assets | $21145 | $21175 | $20504 | $19959 |
| Total investments | $3157 | $3147 | $3254 | $2534 |
| Total assets | $28312 | $27156 | $27579 | $27106 |
| Current liabilities | ||||
| Accounts payable | $1408 | $1504 | $1300 | $1207 |
| Deferred revenue | $110 | $959 | $659 | |
| Short long term debt | $120 | $145 | $135 | $145 |
| Total current liabilities | $4760 | $4476 | $5109 | $4847 |
| Long term debt | $14882 | $14934 | $15511 | $15574 |
| Total noncurrent liabilities | $18044 | $18072 | $18213 | $19370 |
| Total debt | $15002 | $15079 | $15646 | $15719 |
| Total liabilities | $22804 | $26014 | $23322 | $24217 |
| Shareholders' equity | ||||
| Retained earnings | -$192 | -$803 | -$1214 | -$2128 |
| Other shareholder equity | -$181 | -$181 | -$233 | -$281 |
| Total shareholder equity | $1608 | $1142 | $1028 | $28 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5122 | $5103 | $5368 | $5381 |
| Cost of revenue | ||||
| Gross Profit | $4241 | $4195 | $5368 | $5381 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2321 | $2315 | ||
| Total operating expenses | $3476 | $3524 | $2142 | $4719 |
| Operating income | $3226 | $662 | ||
| Income from continuing operations | ||||
| EBIT | $3119 | $534 | ||
| Income tax expense | $241 | $110 | $750 | $63 |
| Interest expense | -$140 | -$142 | $218 | $227 |
| Net income | ||||
| Net income | $472 | $259 | $2151 | $244 |
| Income (for common shares) | $2151 | $244 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20564 | $19368 | $19676 | $18522 |
| Cost of revenue | ||||
| Gross Profit | $20564 | $19368 | $19676 | $18522 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $9146 | $8844 | $8878 | $8418 |
| Total operating expenses | $18282 | $17251 | $17023 | $16702 |
| Operating income | $2282 | $2117 | $2653 | $1820 |
| Income from continuing operations | ||||
| EBIT | $1818 | $1645 | $2248 | $1305 |
| Income tax expense | $306 | $344 | $411 | -$97 |
| Interest expense | $901 | $890 | $923 | $1003 |
| Net income | ||||
| Net income | $611 | $411 | $914 | $399 |
| Income (for common shares) | $611 | $411 | $914 | $399 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $2151 | $244 | ||
| Operating activities | ||||
| Depreciation | $208 | $216 | ||
| Business acquisitions & disposals | -$449 | -$114 | ||
| Stock-based compensation | $17 | $18 | ||
| Total cash flows from operations | $586 | $824 | ||
| Investing activities | ||||
| Capital expenditures | $3790 | -$175 | ||
| Investments | -$3 | -$40 | ||
| Total cash flows from investing | $3801 | $3134 | $3328 | -$333 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$278 | -$110 | ||
| Net borrowings | -$2139 | -$62 | ||
| Total cash flows from financing | -$3313 | -$2815 | -$2661 | -$317 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2866 | $1652 | $1253 | $174 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $611 | $411 | $914 | $399 |
| Operating activities | ||||
| Depreciation | $870 | $841 | $855 | $857 |
| Business acquisitions & disposals | -$224 | -$234 | -$1220 | -$1177 |
| Stock-based compensation | $66 | $56 | $56 | $44 |
| Total cash flows from operations | $2374 | $1083 | $1568 | $3407 |
| Investing activities | ||||
| Capital expenditures | -$680 | -$552 | $590 | -$463 |
| Investments | -$54 | -$16 | -$77 | $15 |
| Total cash flows from investing | -$969 | -$808 | -$714 | -$1608 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$200 | -$250 | $23 | |
| Net borrowings | -$188 | -$852 | -$380 | $477 |
| Total cash flows from financing | -$1035 | -$1781 | -$936 | $385 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $370 | -$1506 | -$82 | $2184 |
News
Fundamentals
| Market cap | $11.44B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 95.08M |
| Revenue | $20.97B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.13B |
| Revenue Q/Q | 1.05% |
| Revenue Y/Y | 3.76% |
| P/E ratio | 3.66 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.55 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $32.88 |
|---|---|
| ROA | 10.79% |
| ROE | N/A |
| Debt/Equity | 14.18 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.58 |
| Quick ratio | 1.52 |